Merck & Co Inc (NYSE:MRK) shares, rose in value, with the stock price up by 1.54% to the previous day’s close as strong demand from buyers drove the stock to $88.95.
Actively observing the price movement in the recent trading, the stock is buoying the session at $87.60, falling within a range of $87.6701 and $89.274. The value of beta (5-year monthly) is 0.363 whereas the PE ratio is 13.21 over 12-month period. Referring to stock’s 52-week performance, its high was $134.63, and the low was $81.04. On the whole, MRK has fluctuated by -1.80% over the past month.
With the market capitalization of Merck & Co Inc currently standing at about $224.69 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-03. The company’s Forward Dividend Ratio is 3.16, with its dividend yield at 3.55%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MRK’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 1.04, with the price of MRK currently trading nearly -4.17% and -3.59% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.87, while the 7-day volatility ratio is showing 2.62% which for the 30-day chart, stands at 2.35%. Furthermore, Merck & Co Inc (MRK)’s beta value is 0.43, and its average true range (ATR) is 2.16.
A comparison of Merck & Co Inc (MRK) with its peers suggests the former has fared considerably weaker in the market. MRK showed an intraday change of 1.54% in today’s session so far, and over the past year, it shrunk by -29.14%%.
Data on historical trading for Merck & Co Inc (NYSE:MRK) indicates that the trading volumes over the past 10 days have averaged 19.07 and over the past 3 months, they’ve averaged 15.82 million. According to company’s latest data on outstanding shares, there are 2.53 billion shares outstanding.
Nearly 0.09% of Merck & Co Inc’s shares belong to company insiders and institutional investors own 80.21% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 37.13 million shares as on 2025-03-14, resulting in a short ratio of 2.19. According to the data, the short interest in Merck & Co Inc (MRK) stood at 147.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 32.21 million. The stock has fallen by -10.59% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MRK stock heading into the next quarter.
